Abstract. Concentrations of glial fibrillary acidic protein (GFAp) and light subunit neurofilament protein (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness. Correlations between GFAp and NFL in CSF as markers for astrogliosis and neurodegeneration, and clinical and biological data were investigated. Abnormal levels of GFAp and NFL were significantly associated with increasing CSF cell number and protein concentration, and with the absence of lymph nodes or the absence of trypanosomes in lymph node aspirate. A significant association was found between abnormal NFL and presence of trypanosomes in CSF, abnormal limb movements, difficulties in gait and coordination, and low Karnofsky index. By multivariate analysis, it was shown that increasing CSF cell number, increasing CSF protein concentration, and the absence of lymph nodes or the absence of trypanosomes in the lymph node aspirate were the best predictors for astrogliosis and neurodegeneration among the variables tested. These results demonstrate the importance of CSF cell count and protein determination in assessment of the severity of central nervous system involvement and reinforces the importance of laboratory diagnosis to assess the stage of the disease. The clinical symptoms studied were less useful in predicting astrogliosis or neurodegeneration.
INTRODUCTION
Infection with the protozoan parasite Trypanosoma brucei gambiense causes sleeping sickness, or human African trypanosomiasis. After the infective tsetse bite, trypanosomes spread into blood and lymphoid tissues, initiating the hemolymphatic disease stage. When trypanosomes invade the central nervous system (CNS), the second, meningoencephalitic stage is initiated. Parasites probably enter the brain via areas with a reduced blood-brain barrier and spread into cerebrospinal fluid (CSF) and stromal spaces via the subarachnoid spaces to the perivascular extensions that pass into the brain. [1] [2] [3] [4] This is associated with chronic meningitis that progresses to encephalitis and is accompanied by extensive perivascular cuffing, infiltration and activation of plasma cells, Mott cells, T-cells, and astrocytes, and by neuronal degeneration. 1, [5] [6] [7] [8] Changes in the composition of CSF reflect events in the CNS. Increased CSF concentrations of glial fibrillary acidic protein (GFAp) indicate astrogliosis, whereas increased light subunit neurofilament protein (NFL) concentrations in CSF reflect neuronal degeneration. 9, 10 Abnormal concentrations of both GFAp and NFL in the CSF of patients with second-stage T. b. gambiense have been reported. 11 Gliosis, neuronal degeneration, or both might explain the clinical symptoms frequently observed in secondstage human African trypanosomiasis, including tremor, fasciculation of the muscles, choreiform, athetoid or oscillatory movements, and increased tonicity or muscular rigidity. 7, [12] [13] [14] [15] A correlation between GFAp and NFL concentrations in CSF and clinical symptoms has been reported for several neurological diseases, including neuroborreliosis, normal pressure hydrocephalus, and multiple sclerosis. [16] [17] [18] [19] In the current study, we investigated which biological indicators (presence of trypanosomes in the lymph node aspirate, presence of trypanosomes in CSF, CSF cell number, and protein concentration) and which clinical symptoms (coordination, abnormal limb movements, tonus, stance, gait, and Karnofsky index) are the best predictors of astrogliosis and neurodegeneration in patients with second-stage sleeping sickness.
MATERIALS AND METHODS
Patients and CSF samples. One hundred twenty-four parasitologically confirmed patients with second-stage T. b. gambiense aged 12-65 years, originating from Arua district, Northern Uganda, were included in the study. Patients were selected at random from a cohort participating in a study on encephalitic reactions that systematically included all second-stage patients visiting the treatment center. Lumbar punctures were performed as part of routine diagnosis and stage determination of patients with human African trypanosomiasis, as prescribed by the World Health Organization (WHO). 20 Patients included in the current study underwent a more extensive clinical examination but received the standard medication: 122 patients were treated with melarsoprol, and 2 patients received eflornithine. The study was approved by the Ugandan Ministry of Health and an oral consent was systematically collected from all patients. Classification of the patients in the second stage, according to WHO guidelines, 20 was based on detection of trypanosomes or the presence of Ͼ 5 cells/L in CSF. Eight of the patients presented themselves for retreatment because they had relapsed after initial treatment.
The following clinical data were collected at admission: abnormal limb movement (absent/present ϩ type of abnormal movement), coordination (normal, difficult, impossible), tonus (normal, increased, decreased), stance (normal, difficult, impossible), gait (normal, difficult or ataxic, impossible), Karnofsky index (a scale quantifying the functional status/performance status ranging from 10% [moribund] to 100% [normal, no evidence of disease]). [21] [22] [23] Trypanosomes were detected in blood by the microhematocrit centrifugation technique or quantitative buffy coat technique, 24, 25 in cervical glands by direct examination of the aspirate (if nodes were present), or in CSF by double centrifugation. 26 Cells in CSF were counted in duplicate in a Nageotte counting chamber. The protein concentration in CSF was determined in duplicate with the bicinchoninic acid protein assay reagent as described by the manufacturer (Pierce, Rockford, IL) using the microtiter plate protocol, with bovine serum albumin as a standard.
Enzyme-linked immunosorbent assay. The GFAp and NFL concentrations in CSF were measured by sandwich enzyme-linked immunosorbent assay. 10, 11, 27 Briefly, microtiter plates were coated with chicken anti-GFAp or anti-NFL immunoglobulin (Ig) G and reference GFAp or NFL, and duplicate samples of CSF were added; wells were incubated with rabbit anti-GFAp or anti-NFL IgG. Peroxidase-conjugated donkey anti-rabbit IgG (Amersham, Buckinghamshire, UK) was added, and plates were developed with o-phenylenediamine and perhydrol. The absorbance was measured at 490 nm. Wells were washed between each step. The GFAp standard curve ranged 16-8,000 ng/L, the NFL standard curve from 62-32,000 ng/L. The concentrations of GFAp and NFL in the samples were interpolated from the standard curves. Cell number and protein concentration in CSF were recoded as categorical variables by quartiles. Karnofsky index was recoded in index 100-80% and index Ͻ 80%, following the condition subdivisions originally described. Index 80-100% was Condition A (patient able to carry on normal activity and to work, no special care needed); index Ͻ 80% was condition B ϩ C (unable to work, but able to care for personal needs; a varying degree of assistance needed, and the patient unable to care for him-or herself). Patients without lymph nodes or without trypanosomes in the lymph node aspirate were considered cervical gland negative. For all clinical and laboratory variables, differences in proportion of abnormal NFL and GFAp concentrations between the groups were assessed by chi-square analysis.
In order to identify the best predictors of astrogliosis and neurodegeneration and to adjust the results on potential confounders, a multivariate analysis was performed by a multiple logistic regression model and the adjusted odds ratio as an estimation of the relative risk. The dependent variables were successively the GFAp and NFL concentration recoded as normal and abnormal. The covariates included both the clinical and the biological variables. Colinearity between covariates was checked by chi-square analysis. When 2 colinear covariates were identified, one was removed from the analysis. All other covariates were included in the initial model and then removed one by one on the basis of the highest P value observed among them. Only the variables with P Ͻ 0.10 were kept in the final model.
RESULTS
The GFAp concentrations measured in CSF were between 34 and 2672 ng/L, with a median of 664 ng/L and abnormal values in 68% of the patients. The NFL concentrations in CSF ranged 125-9,244 ng/L, with a median of 439 ng/L. An abnormal NFL concentration was observed in 65% of the patients.
The proportion of patients with abnormal GFAp significantly increased with cell number and protein concentration in CSF and was significantly higher for cervical gland negative patients (Table 1) . No difference between the subgroups of any of the clinical variables was observed for GFAp.
The percentage of patients abnormal for NFL increased significantly with increasing protein concentration and cell number in CSF and was significantly higher for cervical gland negative patients and patients with trypanosomes in CSF. For the clinical variables, the percentage abnormal for NFL was significantly higher in patients with difficulty in coordination or gait, patients with abnormal limb movements, and patients with Karnofsky indexes Ͻ 80 (Table 1) .
Colinearity was identified between gait and stance, coordination and stance, tonus and stance, gait and coordination, and tonus and gait. Stance, tonus, and coordination were removed from the multivariate analysis. The other covariates were included in the initial multivariate model ( Table 2 ). In the final regression model, only the number of cells and the protein concentration in CSF, as well as the absence of lymph nodes or the absence of trypanosomes in the lymph node aspirate, remained significantly associated with the risk of presenting abnormal GFAp and NFL levels in CSF (Table  2 ).
DISCUSSION
The current study confirms the presence of astrogliosis and neurodegeneration, assessed by the CSF markers GFAp and NFL, observed in patients with second-stage sleeping sickness. 11 Compared with the former study, 11 higher concentrations of GFAp and NFL in the CSF of patients with second-stage sleeping sickness and a higher proportion of patients with abnormal GFAp and NFL were observed. As shown in the current study, this can be explained by higher CSF cell numbers, higher CSF protein concentrations, and a higher number of patients with trypanosomes in the CSF within this study compared with the former study. 11 We found that increased cell number and protein concentration in CSF were associated with abnormal GFAp levels in a higher proportion of patients and were thus predictive for astrogliosis. An increased protein concentration could be the consequence of impairment of the blood-brain barrier, possibly caused by cytokine release from activated astrocytes or microglia. 28 In T. b. brucei-infected mice, detection of interleukin (IL)-6 in the CNS correlates with astrocyte activation, 29 and increased IL-6 and IL-8 concentrations have been detected in the CSF of patients with second-stage sleeping sickness (Lejon V and others, unpublished data). Both cytokines can alter the integrity of the blood-brain barrier 30, 31 and may contribute to the activation, infiltration, and proliferation of plasma, Mott cells, and T cells, and consequently the increased cell numbers in CSF. 32, 33 Increased cell number and protein concentration in CSF were also associated with a higher proportion of patients having abnormal NFL and were thus predictive for neurodegeneration. These events could be the consequence of gli- osis and release of cytotoxic molecules such as NO (Keita M and others, unpublished data) 8,34-37 but could also be linked to the presence of autoantibodies against brain proteins such as myelin basic protein, galactocerebrosides, and neurofilament. [38] [39] [40] Evidence exists that production of antibodies to galactocerebroside and neurofilament is induced by trypanosome components with cross-reactive epitopes. 40, 41 In univariate analysis, a significant association was found between abnormal NFL concentrations and the presence of trypanosomes in CSF. This might be explained by the association between the presence of trypanosomes and increased cell numbers in CSF 42 or by the secretion of toxic molecules into the CSF by trypanosomes, adversely affecting neuronal fibers. 8 A negative lymph node puncture or the absence of lymph nodes as a predictor of CNS pathology might seem surprising. However, a relationship between increasing CSF white blood cell count and absence of trypanosomes in the blood or lymph node aspirate has already been observed, in combination with a higher risk for treatment-induced encephalopathy. 43 It was described in 1906 that glandular enlargements were a constant feature of early stages of trypanosomiasis, and that examination of the lymph node aspirates is indicated for diagnosis of early cases in which all clinical signs are wanting. 44 Ormerod 45 described fibrosis of lymph vessels and shrinking of the lymph glands as characteristic for advanced sleeping sickness. The absence of lymph nodes in patients in the second stage could also indicate an exhausted immune system.
In univariate analysis, a significant association was observed between abnormal neurofilament and abnormal movements of the limbs, coordination, and gait. Because NFL is highly enriched in large myelinated axons, this finding might be compatible with a degeneration of subcortical white matter, cerebellar or spinal tracts such as pyramidal pathways, posterior columns, or cerebellar proprioceptive pathways. This association disappeared in the multivariate model.
We conclude that these clinical symptoms are of less use to assess CNS pathology compared with the biological data. This finding confirms the minor role played by general clinical symptoms in the diagnosis and staging of patients with human African trypanosomiasis. 15, 46, 47 The total CSF protein concentration, the CSF cell number, and the absence of lymph nodes or absence of trypanosomes in lymph node aspirate are more reliable predictors of astrogliosis and neurodegeneration and therefore merit careful monitoring. The predictability of astrogliosis and neurodegeneration by the total protein concentration and the cell number in CSF again stresses the importance of these laboratory analyses for determining the CNS pathology of human African trypanosomiasis.
